首页> 外国专利> 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation

6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation

机译:对氨基酸受体(特别是AMPA受体)具有拮抗作用的6,7-不对称双取代喹喔啉羧酸衍生物及其加成盐及其制备方法

摘要

6,7-Asymmetrically disubstituted quinoxalinecarboxylic acid derivatives represented by a general formula (1) wherein; Q is halogen, alkyl optionally substituted with halogen, or Ar-P-, where Ar is optionally substituted phenyl or naphthyl and P is alkylene, alkenylene, alkynylene, oxygen or sulfur, L-A-, wherein L is of general formula (4) wherein; V is a single bond, alkylene or alkenylene; T is phenyl, naphthyl, heterocycle and its condensed ring, hydrogen, hydroxyl, thiol, optionally substituted amino, alkoxycarbonyl, carboxyl or aldehyde, general formula (4-a) or (4-b) wherein; U and X are oxygen or sulfur; W is aralkyl, phenyl, naphthyl, optionally substituted heterocycle and its condensed ring or alkyl optionally substituted with halogen or cycloalkyl; R3 is aralkyl, phenyl, naphthyl, optionally substituted heterocycle and its condensed ring, hydrogen, alkyl optionally substituted with halogen or cycloalkyl, or general formula (4-c), wherein; X is oxygen or sulfur; W is aralkyl, phenyl, naphthyl, optionally substituted heterocycle and its condensed ring, alkyl optionally substituted with halogen or cycloalkyl; R4and R5 are aralkyl, phenyl, naphthyl, optionally substituted heterocycles and their condensed rings, hydrogen, alkyl optionally substituted with halogen or cycloalkyl; Ring B is an optionally substituted heterocycle and its condensed ring which may contain oxygen, nitrogen or sulfur; m denotes 0 or 1; A is a single bond, alkylene, alkenylene or alkynylene; or Q is general formula (5), wherein; R6 and R7 are hydrogen, alkyl optionally substituted with halogen, cycloalkyl, or optionally substituted phenyl or aralkyl; R1 is aralkyl, phenyl, naphthyl, optionally substituted heterocycle and its condensed ring, hydrogen, alkyl optionally substituted with halogen or cycloalkyl; R2 is a hydroxyl, alkoxy or general formula (6), wherein; R8 and R9 are aralkyl, phenyl, optionally substituted heterocycles and their condensed rings, hydrogen, alkyl optionally substituted with halogen or cycloalkyl, or R8 and R9 may form a ring together with nitrogen, or either of R8 and R9 are hydrogen while the other is a optionally substituted phenyloxy or aralkyloxy hydroxyl group or lower alkoxy group, and R is nitro, trifluoromethyl, optionally substituted amino or general formula (7), wherein; R10 and R11 are aralkyl, phenyl, optionally substituted heterocycles and their condensed rings, hydrogen, alkyl optionally substituted with halogen or cycloalkyl, or R10 and R11 may form a ring together with nitrogen and n is 1 to 2; and their addition salts.
机译:通式(1)表示的6,7-不对称二取代喹喔啉羧酸衍生物,其中; Q为卤素,任选被卤素取代的烷基或Ar-P-,其中Ar为任选取代的苯基或萘基,并且P为亚烷基,亚烯基,亚炔基,氧或硫,LA-,其中L为通式(4),其中; V是单键,亚烷基或亚烯基; T为苯基,萘基,杂环及其稠环,氢,羟基,硫醇,任选取代的氨基,烷氧羰基,羧基或醛,通式(4-a)或(4-b),其中; U和X是氧或硫; W为芳烷基,苯基,萘基,任选取代的杂环及其稠环或任选被卤素或环烷基取代的烷基; R3为芳烷基,苯基,萘基,任选取代的杂环及其稠环,氢,任选被卤素或环烷基取代的烷基或通式(4-c),其中; X是氧或硫; W为芳烷基,苯基,萘基,任选取代的杂环及其稠环,任选被卤素或环烷基取代的烷基; R4和R5是芳烷基,苯基,萘基,任选取代的杂环和它们的稠环,氢,任选被卤素或环烷基取代的烷基;环B为任选取代的杂环及其稠环,其可包含氧,氮或硫; m表示0或1; A为单键,亚烷基,亚烯基或亚炔基;或Q为通式(5),其中; R6和R7是氢,任选被卤素取代的烷基,环烷基或任选取代的苯基或芳烷基; R1为芳烷基,苯基,萘基,任选取代的杂环及其稠环,氢,任选被卤素或环烷基取代的烷基; R2是羟基,烷氧基或通式(6),其中; R 8和R 9是芳烷基,苯基,任选取代的杂环和它们的稠环,氢,任选被卤素或环烷基取代的烷基,或者R 8和R 9可以与氮一起形成环,或者R 8和R 9中的一个是氢,另一个是氢。任选取代的苯氧基或芳烷氧基羟基或低级烷氧基,并且R为硝基,三氟甲基,任选取代的氨基或通式(7),其中; R10和R11是芳烷基,苯基,任选取代的杂环和它们的稠环,氢,任选被卤素或环烷基取代的烷基,或R10和R11可以与氮一起形成环并且n为1-2。及其加成盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号